| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
67,703 |
62,504 |
$8.31M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
41,653 |
37,720 |
$7.75M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
6,892 |
6,661 |
$2.35M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,257 |
14,776 |
$1.66M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,226 |
4,503 |
$1.57M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
14,579 |
6,142 |
$784K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,808 |
1,649 |
$642K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,002 |
10,650 |
$410K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,918 |
5,553 |
$402K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,522 |
2,430 |
$316K |
| 71046 |
Radiologic examination, chest; 2 views |
6,186 |
5,403 |
$314K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,473 |
5,897 |
$228K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
4,510 |
570 |
$174K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
337 |
309 |
$110K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,259 |
1,222 |
$89K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
144 |
137 |
$88K |
| 87081 |
|
13,467 |
12,784 |
$77K |
| 80053 |
Comprehensive metabolic panel |
76,306 |
67,111 |
$75K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
1,420 |
234 |
$71K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,834 |
1,778 |
$59K |
| 71045 |
Radiologic examination, chest; single view |
1,135 |
1,065 |
$57K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
421 |
183 |
$56K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
264 |
253 |
$54K |
| 87581 |
|
1,424 |
1,367 |
$49K |
| 70450 |
Computed tomography, head or brain; without contrast material |
515 |
451 |
$44K |
| 36415 |
Collection of venous blood by venipuncture |
55,981 |
43,603 |
$44K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,335 |
3,121 |
$42K |
| 90791 |
Psychiatric diagnostic evaluation |
342 |
325 |
$37K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
451 |
419 |
$37K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
321 |
290 |
$37K |
| 80061 |
Lipid panel |
3,523 |
3,317 |
$37K |
| 87631 |
|
283 |
253 |
$33K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
105 |
97 |
$28K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
929 |
859 |
$27K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,410 |
3,215 |
$25K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
167 |
102 |
$21K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
430 |
421 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
75,537 |
65,629 |
$20K |
| 86480 |
|
479 |
455 |
$20K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
927 |
858 |
$19K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
635 |
595 |
$17K |
| 29581 |
|
252 |
49 |
$17K |
| G0378 |
Hospital observation service, per hour |
897 |
635 |
$14K |
| 62323 |
|
54 |
38 |
$13K |
| 90834 |
Psychotherapy, 45 minutes with patient |
187 |
88 |
$12K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
85 |
77 |
$10K |
| 83655 |
|
879 |
840 |
$10K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
329 |
316 |
$6K |
| 97803 |
|
817 |
756 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
94 |
93 |
$4K |
| 94060 |
|
27 |
27 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
189 |
178 |
$4K |
| 90832 |
Psychotherapy, 30 minutes with patient |
65 |
37 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
683 |
603 |
$4K |
| 86738 |
|
193 |
181 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
19 |
19 |
$3K |
| 86780 |
|
235 |
223 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
374 |
236 |
$3K |
| 85027 |
|
635 |
556 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,969 |
11,871 |
$3K |
| 80069 |
|
388 |
339 |
$2K |
| 87340 |
|
216 |
207 |
$2K |
| 59025 |
Fetal non-stress test |
16 |
13 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
18 |
18 |
$2K |
| 87480 |
|
344 |
311 |
$2K |
| 87660 |
|
344 |
311 |
$2K |
| 87510 |
|
344 |
311 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14 |
13 |
$2K |
| 94726 |
|
30 |
29 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,996 |
3,675 |
$2K |
| 80050 |
General health panel |
32 |
32 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
17 |
13 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,513 |
3,041 |
$1K |
| 97597 |
|
25 |
12 |
$1K |
| 87088 |
|
241 |
209 |
$1K |
| 84439 |
|
161 |
154 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$943.72 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
27 |
27 |
$878.23 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
18 |
18 |
$851.36 |
| 82570 |
|
156 |
143 |
$671.80 |
| 83721 |
|
125 |
113 |
$654.85 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
394 |
275 |
$629.57 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
9,547 |
7,991 |
$549.02 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,324 |
2,087 |
$377.87 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
19 |
19 |
$365.86 |
| 87486 |
|
19 |
19 |
$365.86 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,456 |
5,079 |
$355.64 |
| 82947 |
|
67 |
39 |
$321.02 |
| J2704 |
Injection, propofol, 10 mg |
1,770 |
1,597 |
$316.70 |
| 73610 |
|
41 |
37 |
$306.84 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,208 |
1,044 |
$303.93 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,356 |
1,259 |
$258.80 |
| 83690 |
|
11,940 |
10,798 |
$257.65 |
| 85610 |
|
3,095 |
2,598 |
$253.86 |
| 81025 |
|
6,022 |
5,464 |
$248.91 |
| 81001 |
|
6,862 |
6,117 |
$247.66 |
| 72100 |
|
13 |
12 |
$243.28 |
| 84153 |
|
13 |
13 |
$231.66 |
| 73630 |
|
31 |
30 |
$230.13 |
| 84484 |
|
7,583 |
5,885 |
$212.87 |
| 85018 |
|
100 |
91 |
$191.16 |
| 83735 |
|
1,135 |
894 |
$176.17 |
| 84156 |
|
67 |
58 |
$166.78 |
| 83540 |
|
47 |
45 |
$163.76 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
22 |
12 |
$162.83 |
| 84466 |
|
28 |
28 |
$159.96 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
16,415 |
14,205 |
$158.75 |
| 84703 |
|
1,330 |
1,273 |
$148.40 |
| 82043 |
|
32 |
31 |
$142.85 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
757 |
632 |
$140.81 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,630 |
689 |
$140.44 |
| 87186 |
|
34 |
32 |
$134.09 |
| 82607 |
|
14 |
13 |
$131.58 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,806 |
1,639 |
$121.05 |
| 82728 |
|
16 |
16 |
$107.99 |
| 84702 |
|
46 |
39 |
$102.13 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
285 |
253 |
$95.75 |
| 86140 |
|
427 |
394 |
$75.30 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,739 |
3,371 |
$69.09 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
17 |
15 |
$42.32 |
| 81003 |
|
1,472 |
1,295 |
$37.11 |
| 85652 |
|
39 |
38 |
$34.06 |
| 82077 |
|
101 |
91 |
$33.48 |
| 85379 |
|
224 |
211 |
$29.58 |
| J3490 |
Unclassified drugs |
1,181 |
985 |
$29.25 |
| 85007 |
|
48 |
44 |
$24.60 |
| 73562 |
|
18 |
16 |
$17.88 |
| 94010 |
|
13 |
13 |
$15.24 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,952 |
1,757 |
$13.26 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
58 |
55 |
$9.75 |
| 82977 |
|
46 |
41 |
$8.21 |
| 83880 |
|
268 |
223 |
$7.17 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
925 |
853 |
$6.35 |
| 85730 |
|
322 |
234 |
$6.19 |
| A9270 |
Non-covered item or service |
42,873 |
37,560 |
$4.54 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
194 |
165 |
$4.48 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
825 |
773 |
$1.75 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
337 |
313 |
$0.53 |
| 94729 |
|
42 |
41 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
43 |
42 |
$0.00 |
| 84145 |
|
32 |
32 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
31 |
25 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
331 |
168 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
316 |
293 |
$0.00 |
| 87807 |
|
556 |
507 |
$0.00 |
| 99156 |
|
18 |
12 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
31 |
30 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
229 |
221 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
29 |
25 |
$0.00 |
| 96376 |
|
49 |
33 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
37 |
27 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
64 |
24 |
$0.00 |
| 82550 |
|
13 |
12 |
$0.00 |
| 83605 |
|
45 |
38 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
20 |
14 |
$0.00 |